| Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice K Boggio, G Nicoletti, E Di Carlo, F Cavallo, L Landuzzi, C Melani, ... The Journal of experimental medicine 188 (3), 589-596, 1998 | 373 | 1998 |
| 2011: the immune hallmarks of cancer F Cavallo, C De Giovanni, P Nanni, G Forni, PL Lollini Cancer Immunology, Immunotherapy 60, 319-326, 2011 | 360 | 2011 |
| Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice P Nanni, G Nicoletti, C De Giovanni, L Landuzzi, E Di Carlo, F Cavallo, ... The Journal of experimental medicine 194 (9), 1195-1206, 2001 | 291 | 2001 |
| Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice E Quaglino, M Iezzi, C Mastini, A Amici, F Pericle, E Di Carlo, SM Pupa, ... Cancer research 64 (8), 2858-2864, 2004 | 199 | 2004 |
| TS/A: a new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinoma P Nanni, C De Giovanni, PL Lollini, G Nicoletti, G Prodi Clinical & experimental metastasis 1, 373-380, 1983 | 165 | 1983 |
| DRAL is a p53-responsive gene whose four and a half LIM domain protein product induces apoptosis FA Scholl, P McLoughlin, E Ehler, C de Giovanni, BW Schäfer The Journal of cell biology 151 (3), 495-506, 2000 | 154 | 2000 |
| Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas. R Ferracini, M Olivero, MF Di Renzo, M Martano, C De Giovanni, P Nanni, ... Oncogene 12 (8), 1697-1705, 1996 | 146 | 1996 |
| Inhibition of tumor growth and enhancement of metastasis after transfection of the γ‐interferon gene PL Lollini, MC Bosco, F Cavallo, C De Giovanni, M Giovarelli, L Landuzzi, ... International journal of cancer 55 (2), 320-329, 1993 | 145 | 1993 |
| Expression of an IGF‐I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells K Scotlandi, S Avnet, S Benini, MC Manara, M Serra, V Cerisano, ... International Journal of Cancer 101 (1), 11-16, 2002 | 131 | 2002 |
| Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-γ and B cell dependent P Nanni, L Landuzzi, G Nicoletti, C De Giovanni, I Rossi, S Croci, A Astolfi, ... The Journal of Immunology 173 (4), 2288-2296, 2004 | 125 | 2004 |
| Molecular and cellular biology of rhabdomyosarcoma C De Giovanni, L Landuzzi, G Nicoletti, PL Lollini, P Nanni Future Oncology 5 (9), 1449-1475, 2009 | 121 | 2009 |
| Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells S Croci, L Landuzzi, A Astolfi, G Nicoletti, A Rosolen, F Sartori, MY Follo, ... Cancer research 64 (5), 1730-1736, 2004 | 120 | 2004 |
| The metastatic ability of Ewing's sarcoma cells is modulated by stem cell factor and by its receptor c-kit L Landuzzi, C De Giovanni, G Nicoletti, I Rossi, C Ricci, A Astolfi, ... The American journal of pathology 157 (6), 2123-2131, 2000 | 117 | 2000 |
| A mutation threshold distinguishes the antitumorigenic effects of the mitochondrial gene MTND1, an oncojanus function G Gasparre, I Kurelac, M Capristo, L Iommarini, A Ghelli, C Ceccarelli, ... Cancer research 71 (19), 6220-6229, 2011 | 113 | 2011 |
| Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells L Menotti, G Nicoletti, V Gatta, S Croci, L Landuzzi, C De Giovanni, ... Proceedings of the National Academy of Sciences 106 (22), 9039-9044, 2009 | 113 | 2009 |
| Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine C De Giovanni, G Nicoletti, L Landuzzi, A Astolfi, S Croci, A Comes, ... Cancer research 64 (11), 4001-4009, 2004 | 109 | 2004 |
| Establishment and characterization of multidrug-resistant human osteosarcoma cell lines. M Serra, K Scotlandi, MC Manara, D Maurici, PL Lollini, C De Giovanni, ... Anticancer research 13 (2), 323-329, 1993 | 106 | 1993 |
| Different mtDNA mutations modify tumor progression in dependence of the degree of respiratory complex I impairment L Iommarini, I Kurelac, M Capristo, MA Calvaruso, V Giorgio, C Bergamini, ... Human molecular genetics 23 (6), 1453-1466, 2014 | 104 | 2014 |
| Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions E Quaglino, S Rolla, M Iezzi, M Spadaro, P Musiani, C De Giovanni, ... The Journal of clinical investigation 113 (5), 709-717, 2004 | 103 | 2004 |
| Respiratory complex I is essential to induce a Warburg profile in mitochondria-defective tumor cells C Calabrese, L Iommarini, I Kurelac, MA Calvaruso, M Capristo, PL Lollini, ... Cancer & metabolism 1, 1-15, 2013 | 102 | 2013 |
